Evidence map›Paper›PMID 32707455›Full record

ArticlePsychiatry research. Neuroimaging2020

Subtyping schizophrenia based on symptomatology and cognition using a data driven approach.

Luis Fs Castro-de-Araujo, Daiane B Machado, Maurício L Barreto, Richard Aa Kanaan

Abstract read
In one paragraph

Article in Psychiatry research. Neuroimaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Luis Fs Castro-de-AraujoCenter of Data and Knowledge Integration for Health (CIDACS). R. Mundo, 121, Salvador BA, Brazil; University of Melbourne, Department of Psychiatry, Austin Health. Studley Road, Heidelberg, Victoria, Australia. Electronic address: ldearaujo@unimelb.edu.au.
Daiane B MachadoCenter of Data and Knowledge Integration for Health (CIDACS). R. Mundo, 121, Salvador BA, Brazil; Centre for Global Mental health (CGMH), London School of Hygiene and Tropical Medicine. King's College London. David Goldberg Centre, De Crespigny Park, London United Kingdom.
Maurício L BarretoCenter of Data and Knowledge Integration for Health (CIDACS). R. Mundo, 121, Salvador BA, Brazil; Institute of Collective Health, UFBA. Rua Basílio da Gama, Salvador BA Brazil. Electronic address: mauricio.barreto@fiocruz.br.
Richard Aa KanaanUniversity of Melbourne, Department of Psychiatry, Austin Health. Studley Road, Heidelberg, Victoria, Australia. Electronic address: richard.kanaan@unimelb.edu.au.

Funding

Wellcome Trust 202912
6 · The paper itself

Abstract

Schizophrenia is a highly heterogeneous disorder, not only in its phenomenology but in its clinical course. This limits the usefulness of the diagnosis as a basis for both research and clinical management. Methods of reducing this heterogeneity may inform the diagnostic classification. With this in mind, we performed k-means clustering with symptom and cognitive measures to generate groups in a machine-driven way. We found that our data was best organised in three clusters: high cognitive performance, high positive symptomatology, low positive symptomatology. We hypothesized that these clusters represented biological categories, which we tested by comparing these groups in terms of brain volumetric information. We included all the groups in an ANCOVA analysis with post hoc tests, where brain volume areas were modelled as dependent variables, controlling for age and estimated intracranial volume. We found six brain volumes significantly differed between the clusters: left caudate, left cuneus, left lateral occipital, left inferior temporal, right lateral, and right pars opercularis. The k-means clustering provides a way of subtyping schizophrenia which appears to have a biological basis, though one that requires both replication and confirmation of its clinical significance.

Indexed as

CognitionBrainCluster AnalysisHumansMagnetic Resonance ImagingSchizophreniaClusteringData-driven subgroupingPositive and negative symptomsSchizophrenia

Identifiers

PMID32707455
PMCPMC7613209

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.